Introduction
Biphenyldicarboxylate (BPDC or DDB) is an intermediate in the synthesis of schisandrin C in Schisandra chinensis (1) . BPDC has been widely used for treatment of liver injury with elevated transaminase induced by chemical poisons and drugs from early 70's in China (2, 3) . Accumulating data have shown that BPDC exerts a protective role in mice from carbon tetrachloride (CCl4)-induced hepatic injuries, by which the serum aspartate aminotransferase (AST) and alanine transaminase (ALT) are dramatically declined, and hepatocyte steatosis and fibrogenesis are also alleviated (4, 5) . BPDC was reported to markedly inhibit the inflammatory response by downregulating the expression of TNF-α (6) , and to exert a curative effect on tamoxifen-induced liver injuries through scavenging reactive oxygen species (ROS) (7) . BPDC was also recognized to enhance liver detoxification and reduce liver damage by activating cytochrome P450 (8) . BPDC represses the invasion and metastasis of MHCC97-H cells (10) , and downregulates the oncogenic c-myc and alpha fetoprotein (AFP), but upregulates the tumor suppressive p53 in Bel-7402 cells (11) . However, BPDC seems not to inhibit the replication and expression of HBV in mice (9) . These results suggested that BPDC may also play an anti-tumor effect except for amelioration of chemical poison-/drug-induced liver injuries.
It has been reported that many microRNAs (miRNAs) are involved in hepatic diseases, such as autoimmune hepatitis (12) , drug-induced liver injury (13, 14) , alcoholic liver disease (15) , non-alcoholic fatty liver disease (NAFLD) (16) , liver fibrosis (17, 18) , and heptocellular carcinoma (HCC) (19, 20) . The miRNA species are a class of endogenous single-stranded RNA molecules comprising of about 22 nucleotides in length, and can post-transcriptionally regulate gene expression. The altered expression of various miRNAs, including miR-122, miR-195, miR-21 and miR-24, have been documented in HCC development, suggesting an involvement of miRNAs in hepatic pathogenesis (21) (22) (23) (24) . However, it has not been filed whether BPDC is implicated in the prevention of hepatic hyperplasia by regulating miRNA profiles.
Here, we report for the first time that BPDC impedes hepatic hyperplasia via upregulating tumor suppressors rather than downregulating tumor markers/oncogenes.
These results should shed light on exploiting the exact mechanism of BPDC in the prevention and treatment of NAFLD and HCC, and would be also beneficial to elucidating the implication of miRNAs in the development of metastasis of hepatic hyperplasia and other hepatic pathogenesis. Table 1 . The copy numbers of amplified genes were calculated using the 2 -ΔΔCт methods.
Materials and methods
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Table 1 Primer sequences for qPCR.
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Results
LPS upregulates liver cancer-specific tumor markers. It is well known that LPS
activates the pattern recognition receptor, toll-like receptor 4 (TLR4), and conveys the inflammatory signal to macrophages, mainly kupffer cells in the liver, causing the release of pro-inflammatory cytokines, such as IL-6, IL-1β and TNF-α. We tried to assess whether LPS-induced TNF-α, IL-1β and IL-6 would be correlated with expression of the specific liver cancer markers, AFP and CEA in mice. For this purpose, we exposed mice to LPS and then measured the hepatic levels of IL-6, IL-1β
and TNF-α, and then quantified the hepatic levels of AFP and CEA.
From these determinations, it could be seen that LPS injection induced a significant high expression of IL-6 (Fig. 1A) , IL-1β (Fig. 1B) and TNF-α (Fig. 1C) .
Accordingly, the hepatic levels of AFP (Fig. 1D) and CEA ( It is generally accepted that microRNAs do not encode the target proteins, but exert their function by regulating the expression of the downstream target genes. Thus, we identified the hepatic level of the potential target protein PTEN. These results indicated that a higher hepatic level of PTEN was measured in BPDC mice than in LPS mice (Fig. 3B ).
In brief, these results unambiguously indicated that LPS-induced miR-21 levels a were predominantly elevated, whereas BPDC downregulated miR-21 and upregulated PTEN in LPS mice, suggesting a reverse correlation of miR-21 with PTEN. 
Discussion
A large number of epidemiological and clinical studies have shown a link between sustained inflammation and increased liver cancer risks, in which more than HCC occurs accounting for 90% in the context of liver injury and inflammation (25, 26) . In the present study, we injected mice with LPS for 8 weeks to mimic a chronic inflammatory milieu, resulting in significant upregulation of pro-inflammatory cytokines and overexpression of HCC-specific biomarkers. From these results, it was anticipated that LPS-driven chronic inflammation can promote HCC by repeatedly activating the immune response and downstream signaling. Indeed, inflammation triggers T cells and macrophages release ROS, leading to oxidative pathogen eradication and organ injuries (27, 28) . Oxidative stresses might result in DNA mutation, which is considered to be the primary underlying cause of cancer (29) .
These results highlight that chronic inflammation is closely correlated with tumorigenesis including HCC and other liver pathogenesis via oxidative stresses.
In recent years, mounting evidence has indicated that activation of oncogenes and loss of function or mutation of tumor suppressor genes are the putative molecular mechanism of tumor onset, and miRNAs expressed aberrantly are involved in physiological processes during tumor development (30, 31) . 
